Ongoing Registry of Treatment of Chronic Venous Diseases (RRT CVD)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03035747 |
Recruitment Status :
Recruiting
First Posted : January 30, 2017
Last Update Posted : February 23, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Varicose Veins of Lower Limb | Procedure: conventional surgery Procedure: endovenous laser ablation Procedure: sclerotherapy Procedure: endovenous radiofrequency ablation Procedure: phlebectomy |
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 5000 participants |
Observational Model: | Other |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 12 Months |
Official Title: | Russian Registry of Treatment of Chronic Venous Diseases |
Actual Study Start Date : | July 2016 |
Estimated Primary Completion Date : | July 2036 |
Estimated Study Completion Date : | July 2036 |

- Procedure: conventional surgery
high ligation and stripping of incompetent saphenous veins
- Procedure: endovenous laser ablation
endovenous laser ablation of incompetent saphenous veins
- Procedure: sclerotherapy
ultrasound guided or catheter or or any other methods sclerotherapy of incompetent saphenous or varicose veins
- Procedure: endovenous radiofrequency ablation
endovenous radiofrequency ablation of incompetent saphenous veins
- Procedure: phlebectomy
hooks phlebectomy of varicose veins
- Change in patency target veins assessed by duplex ultrasonography in different follow up periods after conventional surgery, endovenous thermal ablations, sclerotherapy or non-tumescent non-thermal methods [ Time Frame: Baseline, 3 - 6, 12 months post-intervention ]
- Change in Quality of Life (QoL), assessed by Short form (SF)-36 health survey (optional) [ Time Frame: Baseline, 3 and 12 months post-intervention ]The SF-36 is a generic QoL questionnaire.
- Change in Venous Clinical Severity Score (VCSS) (optional) [ Time Frame: Baseline, 3 and 12 months post-intervention ]The VCSS is a validated scoring system for assessing signs, symptoms and complaints of venous disease.
- Change in Quality of Life (QoL), assessed by Aberdeen Varicose Vein Questionnaire (AVVQ) (optional) [ Time Frame: Baseline, 3 and 12 months post-intervention ]The AVVQ is a disease-specific QoL questionnaire aimed at venous disease.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Varicose veins with any source of pathological reflux, C2 - C6 according to the CEAP classification
Exclusion Criteria:
- no exclusion criteria

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03035747
Contact: Evgeny Ilyukhin, MD, PhD | +79218451722 | evgeny@ilyukhin.info |
Russian Federation | |
Medalp private surgery clinic | Recruiting |
Saint Petersburg, Russian Federation, 197758 | |
Contact: Oleg Shonov, MD shonov.o@gmail.com |
Responsible Party: | Evgeny Ilyukhin, Сhief surgeon Medalp Private Surgery Clinic, Medalp Private Surgery Clinic |
ClinicalTrials.gov Identifier: | NCT03035747 |
Other Study ID Numbers: |
A001 |
First Posted: | January 30, 2017 Key Record Dates |
Last Update Posted: | February 23, 2021 |
Last Verified: | February 2021 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
registry varicose veins conventional surgery thermal ablation |
radiofrequency laser sclerotherapy |
Varicose Veins Vascular Diseases Cardiovascular Diseases |